Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline.
AuthorsMolitch, Mark E
Clemmons, David R
Merriam, George R
Shalet, Stephen M
Vance, Mary Lee
Stephens, Patricia A
AffiliationNorthwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
MetadataShow full item record
AbstractOBJECTIVE: The objective is to provide guidelines for the evaluation and treatment of adults with GH deficiency (GHD). PARTICIPANTS: The chair of the Task Force was selected by the Clinical Guidelines Subcommittee of The Endocrine Society (TES). The chair selected five other endocrinologists and a medical writer, who were approved by the Council. One closed meeting of the group was held. There was no corporate funding, and members of the group received no remuneration. EVIDENCE: Only fully published, peer-reviewed literature was reviewed. The Grades of Evidence used are outlined in the Appendix. CONSENSUS PROCESS: Consensus was achieved through one group meeting and e-mailing of drafts that were written by the group with grammatical/style help from the medical writer. Drafts were reviewed successively by the Clinical Guidelines Subcommittee, the Clinical Affairs Committee, and TES Council, and a version was placed on the TES web site for comments. At each level, the writing group incorporated needed changes. CONCLUSIONS: GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks of GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.
CitationEvaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. 2006, 91 (5):1621-34 J. Clin. Endocrinol. Metab.
JournalThe Journal of Clinical Endocrinology and Metabolism
- Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline.
- Authors: Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine Society.
- Issue date: 2011 Jun
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
- Authors: Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM, Hoffman AR
- Issue date: 2019 Nov
- Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.
- Authors: Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM
- Issue date: 2006 Jun
- Androgen therapy in women: an Endocrine Society Clinical Practice guideline.
- Authors: Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N
- Issue date: 2006 Oct
- Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.
- Authors: Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, Shapiro J, Montori VM, Swiglo BA
- Issue date: 2008 Apr